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AbstrACt
Objective To minimise the intake of industrially produced 
trans fat (I-TF) and decrease the risk of coronary heart 
disease, several countries have implemented a legislative 
restriction on I-TF in foods. The objective of this study was 
to investigate the presence of I-TF in biscuits/cakes/wafers 
in 15 countries of the former Soviet Union that all have a 
high coronary mortality rate compared with countries in 
Western Europe.
Methods Three large supermarkets in 15 capitals were 
visited in 2015 or 2016. Prepackaged biscuits/cakes/
wafers were bought if the list of ingredients disclosed 
that the product contained more than 15 g of fat per 100 
g of product and if partially hydrogenated fat or a similar 
term, including margarine, refined fat or confectionery fat, 
were mentioned. Samples of the foods were subsequently 
analysed for total fat and TF.
results Some 994 products contained more than 2% 
total fat as I-TF (illegal in Denmark). In Armenia, 91 
different products had a mean value (SD) of 21 (11)% 
fat as I-TF. In Estonia, there were eight products with 
14 (10)% fat as I-TF. The other 13 countries had values 
between those of Armenia and Estonia. In several 
countries, a major portion of the products was imported 
from Russia and Ukraine. The mean shelf life (SD) of 673 
packages was 218 (75) days. The % TF in the fat of the 
products produced in Russia and in Ukraine in relation 
to the date of production both declined by approximately 
10% points during the 2-year collection period.
Conclusions The findings suggest that I-TF is used in 
popular foods in all 15 countries of the former Soviet 
Union. Therefore, these findings indicate a possible way for 
some reduction of the high coronary mortality rate in these 
countries.
IntrOduCtIOn
High amounts of trans fat (TF) in food, that 
is, more than 5% TF in total fat, originate 
from the industrial hydrogenation of edible 
oils. Compared with non-hydrogenated oils, 
fats containing industrially produced trans 
fat (I-TF) are solid at room temperature, 
have some technical advantages for food 
processing and prolong the shelf life of prod-
ucts. TF are not synthesised in the human 
body and are not required in the diet but 
are absorbed and metabolised. I-TF can be 
found at varying concentrations in biscuits, 
pastries, margarine, spreads, confectionery 
creams and fillings and fried foods such 
as potato crisps. Fat from ruminants, for 
instance, in dairy products, contains up to 
5% TF (R-TF), which is considerably lower 
than the up to 50% TF that may be present 
in partially hydrogenated fat in human food. 
In a double-blind, randomised controlled 
trial in humans, R-TF and I-TF resulted in 
the same increase in low-density lipoprotein 
(LDL) cholesterol in blood when the two 
different types of fat were provided in the diet 
at the same amount.1 This result suggests that 
R-TF and I-TF have similar harmful effects on 
plasma lipoproteins.
Observational studies suggest that there is 
an association between the dietary intake of 
strengths and limitations of this study
 ► A strength of this study is that the presence of in-
dustrially produced trans fat in popular foods was 
systematically investigated for the first time in each 
of the 15 countries of the former Soviet Union that all 
have a high coronary mortality rate and a population 
of nearly 300 million people.
 ► A limitation of the study is that only prepackaged 
biscuits/cakes/wafers were investigated for trans 
fat, and no other food groups, such as shorten-
ings and margarines, and no unpackaged foods, 
such as baked goods, sweet rolls, pastries, buns 
and even unpackaged biscuits/cakes/wafers, were 
investigated.
 ► A limitation is the assumption that if certain words 
were not present in the list of ingredients, the prod-
uct contained less than 2% total fat as trans fat.
 ► Another limitation is that the average daily intake of 
trans fat was not measured in any of the subgroups 
of the populations but instead was inferred from the 
availability of popular foods with high amounts of 
trans fat in large supermarkets.
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I-TF and increased risk of coronary heart disease (CHD).2 
The association is further corroborated by an association 
between plasma TF levels and CHD.3 Plausible mecha-
nisms for the association involving an increase in plasma 
LDL cholesterol4 and unfavourable ‘beyond lipid effects’ 
on inflammatory cells that are important for atherogen-
esis5 suggest a causal relationship, even with the absence of 
randomised studies with hard clinical endpoints.6 Based 
on the available evidence, Denmark in 2004 and some 
counties in New York, USA, in 2007, legally restricted the 
use of I-TF in the diet. After the restrictions in Denmark, 
there was a 4.3% lower yearly mortality rate due to CHD 
beyond temporal trends.7 A similar decline of 4.5% in 
the CHD mortality rate was found in the counties with 
restrictions in New York compared with that in similar 
counties without restrictions.8 Three and more years 
after the restrictions were enacted in the counties, the 
combined hospital admission rate for myocardial infarc-
tion and stroke events was 6.2% lower than that in similar 
counties without restrictions.9 These findings from two 
different groups of researchers strongly suggest that I-TF 
in the diet promotes CHD and that a restriction in its use 
reduces CHD. What remains to be explored is to what 
extent I-TF is still used in popular foods in countries with 
high rates of CHD mortality.
The 15 countries of the former Soviet Union all have an 
extraordinarily high rate of CHD mortality compared with 
that of countries in Western Europe10 (online supplemen-
tary table A). In a systematic analysis, including 266 coun-
try-specific nutrition surveys, the average consumption of 
TF in 2010 in Central Asia and Eastern Europe, which 
together include the 15 countries of the former Soviet 
Union, for adults more than 20 years old, was 0.9% of total 
energy intake.11 This intake corresponds to approximately 
2.5 g of TF per day per adult and is less than the 1% of the 
total energy recommended by WHO. The consumption 
level was found to be stable since 1990. Among the 21 
different regions in the world, Central Asia and Eastern 
Europe were placed at numbers 5 and 8, respectively, for 
the lowest average consumption of TF, suggesting that the 
intake of TF is a minor health problem in these countries. 
However, the investigators mention the relatively limited 
availability of data on TF consumption in most of these 
nations compared with the availability of data on other 
major dietary factors.11 Furthermore, a low average intake 
of TF in a nation does not exclude a high intake of TF 
in subgroups of the population if popular foods contain 
high amounts of I-TF.
Some recent Russian studies, with an abstract in 
English, mentioned the harmful effect of dietary I-TF on 
health and pledged to remove I-TF from margarine ‘to 
preserve the health of Russia’s population’.12 13 A study 
from Estonia reported on high I-TF in blended spreads, 
margarines and shortenings that were bought in the 
Estonian retail markets in 2011.14 Additionally, technical 
reports from WHO have found several types of street 
foods with high amounts of TF in Dushanbe, Tajikistan in 
April/May 2016 and in Bishkek, Kyrgyzstan in June/July 
2016.15 In a recent systematic review of TF intake and its 
dietary sources in general populations worldwide based 
on data from 29 different countries and a demonstra-
tion of a substantial reduction in I-TF in many countries, 
none of the countries of the former Soviet Union were 
included for either the intake of the general population 
or for the secondary research question of the study about 
the composition of fat in biscuits because of the lack 
of data.16 Apparently, there is a pronounced scarcity of 
newer internationally published data on I-TF in foods in 
most of these countries. The purpose of the present study 
was to investigate the presence of I-TF in popular foods in 
the 15 countries of the former Soviet Union via a newly 
developed market basket method.17
MethOds
Purchase of biscuits/cakes/wafers in supermarkets
By using Wikipedia and local tourist information offices, 
three large supermarkets, preferably chain supermarkets 
with many large shops across the country, were identified 
in each capital.18 Prepackaged biscuits/cakes/wafers were 
chosen as the food to be investigated for TF in this study 
because these types of foods are frequently consumed, 
easily accessible and transportable at ambient tempera-
ture. Furthermore, these foods traditionally contain I-TF-
rich partially hydrogenated vegetable oils as their major 
lipid ingredient, and I-TF has previously been found in 
these foods in high concentrations in some countries 
in Eastern Europe.19–21 The packages of biscuits/cakes/
wafers were obtained in each supermarket by systemati-
cally examining the labels of the products. Packages were 
purchased if their list of ingredients met the following 
criteria:
 ► The total fat content was equal to or exceeded 15 g 
per 100 g of product.
 ► One or more of the following terms was listed: partially 
hydrogenated fat, hydrogenated fat, hardened fat, 
refined fat, confectionery fat, deodorised fat, all-pur-
pose fat or margarine.
 ► If the list of ingredients indicated trans fat >0 g, these 
foods were also included.
 ► Packages with the term ‘unhydrogenated fat,’ ‘fully 
hydrogenated fat’ or ‘no trans fat’ were not purchased.
If the same package with the same barcode number was 
found in more than one of the three different supermar-
kets in the same capital, only the package with the most 
recent production date was included in the study. Each 
package was subsequently labelled with an ID number, 
and duplicate samples of approximately 50 g each of the 
product were taken for analysis. The barcode number, 
the name of the producer, the country of origin and, 
if available, the best-before date as well as the produc-
tion date were recorded, and the empty packages were 
stored. The first two digits (sometimes three digits) of 
the barcode number were used to identify the country 
or economic region numbering authority that assigned 
the manufacturer code. The Russian Federation uses the 
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code 46; Ukraine, 482. The manufacturer code is the next 
five digits, followed by the product code, consisting of five 
digits. The last digit is the check digit.22
To investigate to what extent the presence of biscuits/
cakes/wafers in the capital differed from other parts of 
the country, biscuits/cakes/wafers were obtained from 
three different supermarkets in two different regions 
of the two largest countries Uzbekistan and Russia: in 
Uzbekistan also in the second largest city Samarkand 
(0.4 million inhabitants and approximately 300 km from 
Taskent) and in Russia also in St. Petersburg (5.2 million 
inhabitants and approximately 800 km from Moscow). 
The third largest country was Ukraine. In its capital Kiev, 
three other large supermarkets were visited (Kiev-2) in 
addition to the first three that were visited (Kiev-1).
Analysis of tF
The samples from the various countries were analysed 
successively in the order they were obtained. The samples 
that were obtained from the first countries that were 
visited (Moldova, Belarus, Georgia, Armenia and Kyrgyz-
stan) were all analysed for TF. In the other countries that 
were visited later, some packages were obtained with the 
same barcode number, the same visual appearance and 
list of ingredients as those on packages where the samples 
had already been analysed. A sample from the newly 
found package was analysed only if the best-before date 
on that package exceeded the best-before date by more 
than 12 months on a package that already had been anal-
ysed. Otherwise, the TF values were carried forward to the 
new package (online supplementary table B).
For analysis, the foods were homogenised, and the fatty 
acid content was analysed using gas chromatography on 
a 60 m highly polar capillary column via a modification of 
the Association of Official Analytical Chemists (AOAC) 
996.06 method. Two procedures were modified in minor 
ways. In the AOAC 996.06 method, the final step of the 
extraction/methylation called for 1 mL of hexane to be 
added. In the modified method, 4 mL was added. The 
4 mL of hexane makes it possible to achieve the detec-
tion limit needed for low-fat samples. It provides extra 
volume for subsequent dilutions for high-fat samples 
in order to achieve results that fall within the range of 
the detector. The extra volume also provides additional 
extract for further dilutions and subsequent analysis to 
optimise separation of cis/trans isomers or if more reso-
lution is needed between other fatty acids. In addition, 
in the modified method, C11:0 triundecanoin was used 
as an internal standard. This method makes it possible 
to obtain total fat as triglycerides, which are then broken 
down into monosaturated, polysaturated, saturated and 
total TF. Total TF may consist of up to eight different 
trans fatty acids. Microbac Laboratories in Warrendale, 
Pennsylvania, USA conducted all analytical work on the 
samples. The laboratory underwent annual proficiency 
testing and was audited every other year to ensure compli-
ance of this method with ISO 17025.
From the peaks in the chromatogram, TF was calcu-
lated as a fraction (per cent) of total fat in the product. 
This value is primarily of interest for food producers, 
food chemists and food legislators. The total amount of 
fat in 100 g of the product was determined from the chro-
matogram. When that value was multiplied by the TF frac-
tion, the amount of TF in grams per 100 g of the product 
was calculated. This value is primarily of interest for the 
customers and for investigators studying the health effect 
of intake of TF.
The measurement does not distinguish I-TF from R-TF. 
If butter as a ruminant fat has been used in the product in 
addition to partially hydrogenated vegetable oil, some of 
the TF in the product may be derived from butter that on 
average contains a few per cent and a maximum 5% fat 
as R-TF. In this paper, the term I-TF is used even though 
a minor portion in certain products may be TF derived 
from ruminant fat. If butter is present in a product that 
was analysed for TF in the present study and the value was 
higher than 5% TF of total fat, butter diluted the I-TF in 
the product because butter adds more non-TF than it adds 
TF. Values larger than 5% TF in the product are conse-
quently the minimum values for I-TF as a percentage of 
total fat. In products that contain butter with less than 5% 
TF as a percentage of total fat, the I-TF will be lower than 
the TF value. Such products are less important for the 
health of the consumer than products with much higher 
TF values and of less interest for health authorities and 
food scientists because of their low amounts of TF per 100 
g of product.
Patient and public involvement
Patients and the public were not involved in the present 
study.
statistical analysis
For each country, simple linear regression models were 
used to describe the change in % TF of total fat as a func-
tion of shelf life and over time recorded as a function of 
the date of production. The statistical software R was used 
(R Core Team 2017).
results
The number of different packages obtained in three 
different supermarkets in each of the 15 capitals totalled 
1332. Samples from 1068 packages were analysed, and the 
TF values for each of the remaining 264 packages were 
taken from a similar package with an identical barcode 
but obtained earlier in another country and already 
analysed. Some 994 samples had more than 2% fat as 
TF. The different products in each country were ranked 
according to the I-TF level, which was expressed as grams 
per 100 g of the product (figure 1). This latter value tells 
how much TF the consumer receives when 100 g of the 
product is consumed. Each horizontal bar in each panel 
represents a product with more than 2% fat as TF. The 
number of these products is shown together with the 
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number of packages, given in parentheses that met the 
inclusion criteria. The products depicted in each panel 
are all different, but the same product may appear in 
the panel for two or more countries. The mean values 
of the percentages of fat that were I-TF in the collec-
tion of different products from each of the countries, 
together with the SD and maximum values, are shown. 
These percentages are of interest for food producers and 
for food authorities because they describe the fat that 
has been used in the food. In some products obtained in 
Armenia and in Kyrgyzstan, approximately 50% of the fat 
was I-TF (figure 1).
In the second largest city, Samarkand, in Uzbekistan, 
based on the barcode number, 29% of the packages were 
similar to the packages found in the capital, Taskent. In 
St. Petersburg, Russia, 30% of the products were similar 
to the products found in Moscow. In Kiev-2, which was 
the second collection region, 48% were similar to the 
packages found in the first collection region, Kiev-1. 
Even though most of the products were different in the 
two different regions of the same country, the panels 
that reflect the availability of biscuits/cakes/wafers with 
more than 2% TF in fat are rather similar (figure 2). This 
result suggests that the panels presented for each country 
Figure 1 Amounts of industrially produced trans fat (I-TF) in 100 g of prepackaged biscuits/cakes/wafers purchased from 2015 
to 2016 in three supermarkets in each of the 15 capitals. Each bar in a panel represents a unique product that was bought in 
that capital. N is the number of different products with more than 2% TF in the total fat content. (N) is the number of packages 
that met the inclusion criteria. X is the mean value and the SD of the percentages of I-TF in the total fat of the N products, M is 
the maximal value of I-TF as a percentage of total fat. Each bar in all 15 panels has the same thickness, which means that the 
area of the bars is comparable between the different panels.
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in figure 1 represent a pattern found elsewhere in the 
country and not only in the capital.
For the 994 products with more than 2% fat as I-TF and 
that were obtained in the 15 capitals of the former Soviet 
Union, 52% were produced in Russia, 26% in Ukraine, 
13% in own country and 8% in some other countries, 
such as Poland and Bulgaria (table 1). For the products 
produced in Russia, 85% were obtained outside of Russia 
and in the other countries of the former Soviet Union 
combined, not including Ukraine and Lithuania. For 
the products produced in Ukraine, 69% were obtained 
outside of Ukraine in the other countries, excluding 
Russia. The import patterns of prepackaged biscuits/
cakes/wafers that differed from country to country were 
exemplified by the patterns observed in Uzbekistan and 
Kazakhstan (figure 3). The concentrations in grams of TF 
per 100 g of product are shown in a panel for each of 
the two countries, and each product is placed together 
with other products from the same country of origin. The 
numbers and the mean values of the concentrations of TF 
in the fat of prepackaged biscuits/cakes/wafers produced 
in Russia and in Ukraine but obtained in the various coun-
tries of the former Soviet Union are shown in table 1. 
All of the 75 different products with more than 2% fat 
as TF obtained in Moscow were produced in Russia, and 
81 of the 83 different products obtained in Kiev-1 were 
produced in Ukraine. The same pattern was observed 
in St. Petersburg, Russia and Kiev-2, Ukraine. In each of 
the countries, except for the three Baltic countries and 
Belarus, a majority of the products were imported from 
Russia and Ukraine.
The analysis of shelf life was only conducted for pack-
ages produced in Russia and Ukraine, as they were the 
main exporters to most of the other countries, and in 
many of the products, especially from Russia, the length 
of the shelf life in months or days appeared on the 
package together with the date of production. This is in 
contrast to prepackaged biscuits/cakes/wafers produced 
in most countries in the more western part of Europe. 
These packages only have the best-before date, and the 
shelf life of the product is usually hidden from the final 
customer. Products with less than 2% TF in the fat had 
shelf lives of approximately 200 days, which is comparable 
with that of products with a much higher concentration 
of TF (table 2). The most frequent length of shelf life 
was 6 months, whether the products were produced in 
Russia or in Ukraine. The slope of the regression line 
between shelf life and % TF of total fat was significantly 
negative for Ukraine (p<0.0001) and significantly positive 
for Russia (p<0.0001). Taken together, the data did not 
support the conclusion that the higher the concentration 
of TF in the product, the longer was the shelf life.
Since the samples of biscuits/cakes/wafers were 
collected between January 2015 and January 2017 and 
many were produced in Russia and in Ukraine, the % TF 
of total fat in the product was depicted in relation to the 
date of production. The TF concentrations decreased 
significantly during the 2 years in Russia (p<0.0001) as 
well as in Ukraine (p<0.0001), but the decrease did not 
differ significantly between the two countries (p=0.12) 
(figure 4). The products from Ukraine had a higher % TF 
at the start of the period than the products from Russia. 
Based on the slopes of the regression lines in figure 4, the 
decline for the products from Ukraine was 12.4% points 
and for products from Russia 8.4% points during the 
2-year period.
dIsCussIOn
Principal findings
The findings of this study clearly demonstrate that from 
2015 to 2016, I-TF was present in high concentrations, 
that is, more than 5% I-TF in the total fat, in many 
different brands of biscuits/cakes/wafers in the countries 
of the former Soviet Union, except for the three Baltic 
countries. This information was not previously available 
and may be of relevance because of the high coronary 
mortality rate in these countries. In three of the countries, 
Russia, Ukraine and Belarus, by far most of the products 
were produced in the country itself. For the other coun-
tries, except for the three Baltic countries, the imports 
from food producers in Russia and Ukraine made up a 
major portion of their products with high amounts of TF.
In all of the shops, there were more packages containing 
biscuits/cakes/wafers that did not have the inclusion 
terms on the label than packages that had one or more of 
the terms on the label. This result suggests that there are 
plenty of biscuits/cakes/wafers without I-TF available in 
all of the 45 supermarkets. Of the 1332 packages that met 
Figure 2 Legend for this figure is similar to the legend for 
figure 1. The four upper panels show the results for two of 
the capitals and for two other large cities in the same country. 
The lowest two panels show the results from purchases from 
three large supermarkets in Kiev (Kiev-1) and from three other 
large supermarkets in the same city (Kiev-2).
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the inclusion criteria and were bought, 335 (25%) of the 
products had less than 2% fat as TF. This result suggests 
that the inclusion criteria are rather broad in relation to 
the presence of TF and/or that the terms on the list of 
ingredients do not always reflect the composition of the 
fat in the product. If the list of ingredients did not have 
the inclusion words, the product may still have had high 
amounts of TF but were not bought and analysed for TF.
The amount of TF per 100 g of product that was bought 
in Moscow did not exceed 6 g (figure 1), whereas several 
products that were produced in Russia but obtained in 
the other countries, such as Uzbekistan and Kazakhstan, 
had more than 6 g per 100 g (figure 3). The same was 
seen for the average concentration of I-TF in fat in prod-
ucts that were obtained in Russia, which had a mean value 
and SD of 10 (6)%, compared with considerably higher 
values in Russian products that were obtained in the 
other countries (table 1). The same pattern was observed 
for products that were bought in Ukraine and compared 
with products that were produced in Ukraine but bought 
in some of the other countries (table 1). The products 
that were obtained in Russia were bought more than a 
year later than the products that were produced in Russia 
but obtained in the other countries. This same trend 
was also the case for the products that were obtained in 
Ukraine and outside of Ukraine. Some of the difference 
may be due to a decrease in the use of I-TF during the 
time period (figure 4).
I-TF has also been used in foods such as biscuits/cakes/
wafers because it apparently prolongs the shelf life of the 
foods. This fact is presently not supported by the findings 
of this study because 186 products that were produced 
in Russia with a shelf life of 6 months had TF concentra-
tions of 11 (7)% mean value (SD) and 37 products with a 
shelf life of 12 months also had TF concentrations of 11 
(7)%. The corresponding values for products that were 
produced in Ukraine were for 86 products with a shelf life 
Figure 3 Amounts of industrially produced trans fat in 100 g 
of prepackaged biscuits/cakes/wafers that were obtained in 
Uzbekistan and in Kazakhstan, with each product in the panel 
placed together with other products from the same country 
of origin.
Table 2 Shelf life of prepackaged biscuits/cakes/wafers 
produced in Russia and Ukraine
Produced in Russia Produced in Ukraine
Trans fat as % of fat <2% ≥2% <2% ≥2%
No of samples* 140 453 24 220
Shelf life in days
  Mean (SD) 202 (83) 219 (70) 286 (94) 215 (85)
  Range 59–547 46–396 123–366 46–546
*Samples obtained in Samarkand, St. Petersburg and Kiev-2 were 
included if these samples had their own trans fat analysis and a 
readable shelf life on the package.
Figure 4 Date of production and industrially produced trans 
fat (I-TF) as a percentage of total fat for prepackaged 
biscuits/cakes/wafers that were produced in Russia or 
Ukraine and obtained in the countries of the former Soviet 
Union between January 2015 and January 2017. Products 
obtained in Samarkand, St. Petersburg and Kiev-2 were 
included if the products had their own trans fat analysis. Only 
products with more than 2% fat as I-TF were included.  
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of 6 months, 20 (9)% and for 30 products with a shelf life 
of 12 months, 10 (6)%.
Based on the plasma concentrations of TF in nationally 
representative groups in 2010 in the USA (3 years after the 
introduction of mandatory labelling of TF on prepack-
aged foods and despite a nearly 50% lower average TF 
concentration in plasma), there is still a subgroup with 
very high TF concentrations, reflecting a subgroup in the 
general population with a high consumption of TF.4 A 
vicious cycle apparently occurs: as long as foods with high 
amounts of I-TF are present in shops, some consumers 
will buy them, and as long as they are bought, the foods 
will be available. This cycle may also occur in the coun-
tries of the former Soviet Union. Despite a decline in 
the average intake of I-TF in many countries in Western 
Europe,16 in 2015, WHO estimated that millions of Euro-
peans still consume TF at levels that significantly increase 
their risk of CHD.23 The findings reported in the present 
investigation confirm this estimate.
strength and weaknesses of the study
The strengths of this study include that the same proce-
dure was used to obtain popular foods in large supermar-
kets in all 15 countries of the former Soviet Union and in 
two different regions in the three largest countries and 
that the samples were analysed for TF in the same labora-
tory. A limitation of this study is that no other food groups 
(such as shortenings and margarines) and no unpackaged 
foods (such as baked goods, sweet rolls, pastries, buns 
and even unpackaged biscuits/cakes/wafers) were inves-
tigated. It was also assumed that if the inclusion words 
are not present in the list of ingredients, the product 
contained less than 2% total fat as TF. The presence of 
high concentrations of I-TF in biscuits/cakes/wafers may 
be a sign that I-TF is used in other foods as well. Another 
limitation is that the average daily intake of I-TF was not 
measured in any subgroups of the populations but instead 
was inferred from the availability of popular foods with 
high amounts of I-TF in large supermarkets. The compe-
tition for shelf space in supermarkets is usually fierce. If 
products do not sell, they are rapidly replaced by other 
products. A relevant subgroup for intake studies would 
be the consumers who buy prepackaged biscuits/cakes/
wafers.
legislation and I-tF in foods
In the USA in 2015, the Food and Drug Administration 
revoked the previous GRAS (Generally Recognized As 
Safe) status of partially hydrogenated oils, which was a 
step that may remove I-TF from food production in the 
USA before July 2018, and Canada is following suit.24 In 
2009, Austria and Switzerland introduced a legislative ban 
similar to the Danish ban from 2004, followed by Iceland 
in 2011, Hungary and Norway in 2014, and initiated by 
Latvia, Georgia, Lithuania, Slovenia and other Eastern 
European countries including Russia between 2016 and 
2018.13 25–27 The samples for the present study were all 
collected in the various capitals in 2015 or 2016 (online 
supplementary table A) before any of the legislative 
restrictions of I-TF in food were fully implemented in 
these countries. However, some of their food producers 
were most likely aware of future legislation. The producers 
may have gradually started to remove I-TF from some of 
their products in 2015 and 2016. This removal may be 
the explanation for the relatively few products with TF 
in Lithuania and in Latvia. This explanation is appar-
ently not valid for Estonia, which only had eight products 
with more than 2% fat as TF and has no internationally 
published plan for a legislation similar to the two other 
Baltic countries (figure 1 and table 1).
The European Union published a report in 2015, 
which was originally commissioned in 2011, that ‘indi-
cates the need to continue and expedite work in this area 
by collecting more information’.28 29 In the WHO-Europe 
investigation of the various ways to reduce I-TF in foods, 
it was concluded that establishing a legal limit for the 
content of I-TF in foods is potentially the only available 
option that reduces the risks associated with I-TF faced 
by all consumers and that doing so may contribute to 
reducing inequalities. Such a policy is unique in its combi-
nation of efficacy, cost-effectiveness and a low potential 
for negative impact. Removing I-TF from the food supply 
is possibly one of the most straightforward public health 
interventions for reducing the risk of CHD.23 The trend of 
using fat with lower amounts of I-TF (figure 4) over time 
will probably accelerate in 2018 among food factories in 
Russia due to the Russian legislation27 and among facto-
ries in Ukraine due to competition with Russian facto-
ries. The intake of I-TF in the two largest countries may 
decrease, along with the intake of I-TF among millions 
of inhabitants in the adjacent countries due to the large 
export of biscuits/cakes/wafers from Russia and Ukraine 
to these countries18 (table 1).
Future research and implications for policy-makers
It is of considerable interest whether coronary mortality 
and admission rates for CHD and stroke will change in 
countries that have recently introduced legislation that 
restricts the use of I-TF or intend to do so in the near 
future in the same way these rates changed in Denmark 
and in certain counties in New York.7–9
On the basis of data from 2009 to 2011, there is a five-
fold difference in age-standardised mortality rates of CHD 
between some countries in Western Europe and countries 
in Central and Eastern Europe, with Central Asia having the 
highest rates.10 Central Eastern Europe and Central Asia are 
the regions in the world with the highest current age-stan-
dardised cardiovascular mortality rates, which are more than 
twice those of Latin America and the Caribbean.30 These 
differences cannot be explained only by differences in the 
intake of I-TF between the countries. The present study 
demonstrates that there is a presence of I-TF in popular 
foods in the countries of the former Soviet Union, which 
have excessively high CHD mortality rates. The restric-
tion of the use of I-TF in foods, either voluntarily by food 
producers or more efficiently by legislation, may be an easily 
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implemented primary strategy for some reduction of cardio-
vascular diseases in these countries.
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